Elsevier Inc.

SHERPA: Unknown

People

  1. Kris
    Kris
  2. Riely
    Riely
  3. Drilon
    Drilon
  4. Chaft
    Chaft
  5. Yu
    Yu
  6. Paik
    Paik
  7. Rusch
    Rusch
  8. Wu
    Wu
  9. Rudin
    Rudin
  10. Zauderer
    Zauderer

Groups

  1. Department of Medicine (664)
  2. Solid Tumor Oncology Division (664)
  3. Thoracic Oncology (664)
  4. GSK Faculty (169)
  5. Surgery (124)
  6. Radiation Oncology, Department of (110)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (106)
  8. Human Oncology and Pathogenesis Program (78)
  9. Sloan Kettering Institute Postdocs (77)
  10. Epidemiology and Biostatistics (76)
Search Within
  1. "Thoracic Oncology"
Formats
  1. Meeting Abstract (439)
  2. Journal Article (201)
  3. Conference Paper (8)
  4. Review (7)
  5. Editorial (4)
  6. Correspondence (3)
  7. Book Section (1)
  8. Research Letter (1)
Groups
  1. Department of Medicine (664)
  2. Solid Tumor Oncology Division (664)
  3. Thoracic Oncology (664)
  4. GSK Faculty (169)
  5. Surgery (124)
  6. Radiation Oncology, Department of (110)

More Groups

People
  1. Mark Kris (169)
  2. Gregory Riely (133)
  3. Alexander Drilon (107)
  4. Andreas Rimner (97)
  5. Charles Rudin (97)
  6. Jamie Chaft (89)

More People

Years
  1. 2024 (7)
  2. 2023 (68)
  3. 2022 (64)
  4. 2021 (88)
  5. 2020 (28)
  6. 2019 (60)

More Years

Publications
  1. Journal of Thoracic Oncology (466)
  2. International Journal of Radiation Oncology, Biology, Physics (80)
  3. European Journal of Cancer (37)
  4. Clinical Lung Cancer (20)
  5. Seminars in Oncology (18)
  6. Radiotherapy and Oncology (9)

More Publications

Results (664)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Trends in location of death for individuals with metastatic lung cancer in the United States
    Editorial

    Jain, U.; Jain, B.; Dee, E. C.; Bajaj, S. S.; Paguio, J. A.; Yao, J. S.; Gomez, D. R.; Celi, L. A.; Drilon, A.
    American Journal of Surgery (2023)

    Fulltext@MSK | Save
  • Clinicopathologic and genomic factors impacting efficacy of first-line chemoimmunotherapy in advanced NSCLC
    Journal Article

    Alessi, J. V.; Elkrief, A.; Ricciuti, B.; Wang, X.; Cortellini, A.; Vaz, V. R.; Lamberti, G.; Frias, R. L.; Venkatraman, D.; Fulgenzi, C. A. M.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Letter to the editor: Reply to Zhao, Wu, and Ma
    Correspondence

    Alessi, J. V.; Elkrief, A.; Ricciuti, B.; Schoenfeld, A. J.; Awad, M. M.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • RESILIENT part 2: A randomized, open-label phase III study of liposomal irinotecan versus topotecan in adults with relapsed small cell lung cancer (SCLC)
    Meeting Abstract

    Rudin, C. M.; Dowlati, A.; Chen, Y.; Mendivil, A. F. Navarro; Yang, J. C. H.; Stojanovic, G.; Rich, P.; Andric, Z. G.; Wu, Y. L.; Chen, H.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Efficacy and ctDNA analysis in an updated cohort of patients with TRK fusion lung cancer treated with larotrectinib
    Meeting Abstract

    Hoejgaard, M.; Drilon, A.; Lin, J. J.; Kummar, S.; Tan, D. S. W.; Patel, J.; Leyvraz, S.; Garcia, V. Moreno; Rosen, L. S.; Solomon, B.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Efficacy of first-line (1L) nivolumab (N) + ipilimumab (I) by tumor histologic subtype in patients (pts) with metastatic nonsquamous NSCLC (mNSQ-NSCLC)
    Meeting Abstract

    Borghaei, H.; Balli, D.; Paz-Ares, L.; Reck, M.; Ramalingam, S. S.; Brahmer, J. R.; Ciuleanu, T. E.; Pluzanski, A.; Lee, J. S.; Gainor, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Central nervous system disease in patients with RET fusion-positive NSCLC treated with selpercatinib
    Journal Article

    Murciano-Goroff, Y. R.; Falcon, C. J.; Lin, S. T.; Chacko, C.; Grimaldi, G.; Liu, D.; Wilhelm, C.; Iasonos, A.; Drilon, A.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228
    Journal Article

    Paik, P. K.; Fan, P. D.; Qeriqi, B.; Namakydoust, A.; Daly, B.; Ahn, L.; Kim, R.; Plodkowski, A.; Ni, A.; Chang, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Baseline radiomic signature to estimate overall survival in patients with NSCLC
    Journal Article

    Dercle, L.; Fronheiser, M.; Rizvi, N. A.; Hellmann, M. D.; Maier, S.; Hayes, W.; Yang, H.; Guo, P.; Fojo, T.; Schwartz, L. H.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Organizing precision medicine: A case study of Memorial Sloan Kettering Cancer Center's engagement in/with genomics
    Journal Article

    Polk, J. B.; Campbell, J.; Drilon, A. E.; Keating, P.; Cambrosio, A.
    Social Science and Medicine (2023)

    Fulltext@MSK | Save